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Failure of arteriovenous fistula maturation: An
unintended consequence of exceeding Dialysis
Outcome Quality Initiative guidelines for
hemodialysis access
Sheela T. Patel, MD, John Hughes, MD, and Joseph L. Mills Sr, MD, Tucson, Ariz
Purpose: The Dialysis Outcome Quality Initiative (DOQI) guidelines recommend that arteriovenous fistulas (AVF) be
constructed in at least 50% of hemodialysis access procedures. Preoperative duplex ultrasound (US) scanning and
venography may increase options for AVF with identification of veins that are not clinically evident. However, maturation
of autogenous fistulas created on the basis of findings at duplex US scanning and venography has not been carefully
examined.
Methods: From January 1999 to July 2002, 256 new hemodialysis access procedures were performed in 202 patients in an
academic tertiary care center. If physical examination failed to disclose adequate vessels for hemodialysis access, patients
underwent duplex US scanning mapping. Venography was performed when no usable vein or only a basilic vein was
identified at duplex US scanning. Functional maturation rate and mean maturation time (time from fistula creation to
initiation of hemodialysis) were determined. This experience was compared with that in a group of 128 patients in whom
148 hemodialysis access fistulas were created before we implemented liberal use of preoperative duplex US scanning and
venography (January 1997–December 1998).
Results: From January 1999 to July 2002, preoperative duplex US scanning was performed in 68% of patients, and
venography in 32% of patients. Autogenous fistula creation rate increased from 61% to 73% in all patients with
hemodialysis access fistulas (P .15) and from 66% to 83% in patients undergoing a first access procedure (P < .05). The
use of basilic vein transposition also increased, from 3% in the earlier period to 13% in the later period (P < .05). Mean
maturation time for arteriovenous fistulas was 70 days. Functional maturation rate decreased from 73% to 57% (P < .05)
after implementation of preoperative imaging and more aggressive vein use.
Conclusion: Implementation of preoperative duplex US scanning and venography as a component of a more aggressive
protocol to create native fistulas was pivotal in exceeding DOQI guidelines for hemodialysis access. However, this
approach resulted in the unintended sequela of decreased fistula maturation rate. Our experience suggests that improved
selection criteria based on findings at preoperative imaging are needed to further refine and optimize arteriovenous access
surgery. (J Vasc Surg 2003;38:439-45.)
Approximately 300,000 patients in the United States
are receiving long-term hemodialysis, resulting in an annual
health care expenditure in excess of two billion dollars.
Approximately 30% of these costs result from efforts to
maintain access site patency.1 Clinical protocols to opti-
mize patency and function of hemodialysis access sites
could lead to substantial reduction in both patient morbid-
ity and health care costs. It is well-established that arterio-
venous fistulas (AVF) exhibit superior long-term function
compared with prosthetic arteriovenous grafts.2-7 Further-
more, AVF result in fewer infectious and ischemic compli-
cations compared with prosthetic arteriovenous grafts.5,6
In 1997 (updated in 2001), The National Kidney Founda-
tion Dialysis Outcomes Quality Initiative (DOQI) pro-
posed guidelines that AVF be constructed in at least 50% of
permanent hemodialysis access procedures, to improve
quality of life and outcome in patients with end-stage renal
disease. An additional DOQI goal was to achieve an AVF
prevalence of 40% in all hemodialysis patients.8,9 Data
reported in The Dartmouth Atlas of Vascular Health
Care10 demonstrated that we fall far below this objective in
the United States. Native AVF composed only 17% of all
initial permanent hemodialysis access procedures per-
formed in Medicare patients from 1996 to 1997.10 In
2002, the Dialysis Outcomes and Practice Patterns Study
(DOPPS), one of the largest prospective observational
studies published on hemodialysis practices and outcome in
309 international dialysis facilities, reported that AVF ac-
counted for 24% of all access procedures in the United
States, compared with 80% in Europe.7
Since publication of DOQI guidelines, there has been a
strong impetus in the vascular community to increase the
AVF creation rate in vascular access practice. With the
implementation of preoperative imaging protocols that
include routine venous duplex US scanning in conjunction
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with selective venography and arteriography, several au-
thors have reported an increase in AVF creation rate to a
level exceeding the 50% recommended rate endorsed by
DOQI.5,11-15 Such protocols potentially increase options
for AVF by identifying veins that were not evident at
physical examination. Silva et al11 increased the rate of AVF
creation in their practice from 14% to 63% with introduc-
tion of this preoperative imaging protocol. Ascher et al5
observed an increase in autologous fistula creation, from 5%
to 68%, in their practice. Huber et al12 created AVF in 90%
of hemodialysis access procedures on the basis of an algo-
rithm incorporating preoperative duplex US scanning and
arteriography or venography in all patients.
AVF, however, may be associated with several disad-
vantages. Reported AVF maturation rate varies widely,
from 30% to 90%.11-13,16 Lower maturation rate may effec-
tively reduce the functional patency of AVF to a level
approaching that of prosthetic arteriovenous grafts.17,18
Furthermore, AVF require a longer period of maturation
compared with prosthetic arteriovenous grafts. Protracted
hemodialysis via percutaneous catheter may be required
while awaiting fistula maturation, leading to increased risk
for infection and compromised central vein patency. Overly
aggressive attempts to increase AVF creation rate by means
of extensive imaging methods may be detrimental to some
patients. Before publication of the DOQI guidelines, our
approach was to attempt native AVF whenever possible,
with determination of the planned access procedure based
primarily on findings at physical examination. In January
1999 we initiated a more aggressive protocol of preopera-
tive imaging, in an attempt to maximize AVF creation rate
in patients with first-time access and in patients in whom
previous access sites had failed. We evaluated the success of
arteriovenous access procedures performed after imple-
mentation of a preoperative imaging protocol, to deter-
mine whether overall access maturation rate was improved
with such a dedicated protocol.
METHODS
A retrospective review was conducted of data for
patients referred for permanent hemodialysis access to
the vascular surgery practice at the University of Arizona
Health Sciences Center. From January 1999 to July
2002, a prospective imaging protocol was used preoper-
atively to increase AVF rate (study group). This experi-
ence was compared with that in patients in whom per-
manent hemodialysis access was created from January
1997 to December 1998, before implementation of
liberal preoperative duplex US scanning and venography
(historical control group). Demographic data compiled
included gender, race, age, comorbid conditions, and
cause of end-stage renal disease.
Preoperative evaluation included careful assessment of
the vascular anatomy. The nondominant upper extremity
was preferred for creation of an access site; however, the
final decision was ultimately determined according to size
and quality of the vessels. Arterial examination included
pulse assessment, performance of the Allen test, and bilat-
eral upper extremity blood pressure measurement. Venous
examination included inspection and palpation of the ce-
phalic vein at the wrist and upper arm and the basilic vein at
the elbow, with a tourniquet in place. If an acceptable vein
was apparent at the wrist that transmitted a percussed wave
a distance up the forearm, a radiocephalic fistula was
planned.
If physical examination failed to disclose adequate ves-
sels or there was uncertainty regarding the quality or con-
tinuity of the vein for arteriovenous access (ie, history of
multiple venipunctures), patients underwent duplex US
scanning mapping, performed by a registered vascular tech-
nologist in an accredited vascular laboratory (Intersocietal
Commission for the Accreditation of Vascular Laborato-
ries). Patients were examined while reclining, with the arm
dependent. Warm ultrasound gel was applied, and veins
were insonated with a 5 or 7 MHz scanning probe (HDI
2000 and UltraMark 9; Advanced Technology Laboratory,
Bothell, Wash). Duplex US scanning was initiated at the
wrist before and after proximal venous tourniquet occlu-
sion at the mid-forearm. Veins were assessed for ease of
compressibility, distensibility, diameter, thickness, conti-
nuity, and depth below the skin. The tourniquet was then
moved to the arm, and the forearm veins were followed
proximally. The acceptable threshold diameter for vein use
was 2.5 mm or greater. Measurements of vein diameter
were recorded from the ultrasound scans at representative
sites, including wrist, distal forearm, mid-forearm, proximal
forearm, antecubital fossa, distal upper arm, mid–upper
arm, and proximal upper arm. Axillary and subclavian veins
were assessed for patency. Brachial, radial, and ulnar arteries
were evaluated for calcification. Segmental pressure and
velocity waveforms were obtained. Diameter of the radial
artery at the wrist and the brachial artery immediately above
the antecubital fossa were also determined.
Venography was performed selectively if no suitable
vein was identified at duplex US scanning. Venography also
was performed if the only suitable vein identified at duplex
US scanning was the upper basilic vein, to confirm that no
usable forearm or upper arm cephalic vein was overlooked.
Unexplained edema of the upper extremity, presence of
subcutaneous collateral veins across the shoulders and
chest, or extensive history of central venous cannulation
also mandated venography to exclude central vein stenosis
or occlusion. A superficial vein in the hand or forearm was
cannulated, contrast agent was injected, and, with sequen-
tial tourniquet placement, the venous circulation from the
superficial veins to the superior vena cava was imaged, to
assess diameter and continuity.
The choice of access configuration was made on the
basis of results of clinical examination and imaging. Local,
regional, and general endotracheal anesthetic techniques
were selected on the basis of the site of the planned proce-
dure and the preferences of the anesthesiologist, surgeon,
and patient. Most hemodialysis access procedures were
performed on an outpatient basis. Patients were followed
up in the outpatient clinic within 7 to 10 postoperative days
and monthly thereafter until the fistula was sufficiently
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mature for cannulation. Determination of adequate matu-
ration for hemodialysis access was made by the vascular
surgeon and nephrologist on the basis of thrill characteris-
tics and AVF diameter. Diagnostic duplex US scanning for
AVF was performed in cases of failure of adequate matura-
tion by 4 to 6 weeks.
Information regarding cannulation dates was obtained
from 10 regional dialysis centers. Each dialysis center had a
database that recorded dates of dialysis sessions. Functional
maturation was defined as time from the operative proce-
dure to initiation of sustained hemodialysis (cannulated on
four occasions) via the index access. Differences between
the two groups were analyzed with two-tailed Student t test
for continuous variables, and 2 test for categoric variables.
Multivariate analysis incorporating demographic data, co-
morbid conditions, dialysis history, fistula configuration,
use of imaging (duplex US scanning, venography), and vein
diameter (2.5-3 cm, 3 cm) were performed with logistic
regression to predict failed maturation. Statistical analysis
was performed with SPSS software for Windows (version
11.5; SPSS Sciences, Chicago, Ill). P less than .05 was
considered statistically significant.
RESULTS
Between January 1999 and July 2002, 256 access
procedures were performed in 202 patients, who com-
posed the study group. All procedures were performed
by resident trainees under careful supervision of two
experienced vascular surgeons (J.L.M., J.D.H.). The
historical control group consisted of 148 access proce-
dures performed in 128 patients between January 1997
and December 1998. Demographic data for the two
groups are compared in Table I. The study group in-
cluded a higher percentage of women than men (55% vs
45%), but this difference was not statistically significant.
There were no significant differences in age, race distri-
bution, and incidence of comorbid conditions between
the two groups. The study group had fewer patients
undergoing first-time access site creation (63% vs 78%;
P  .08) and significantly more patients receiving hemo-
dialysis at the time of access placement (36% vs 16%;
P  .05). Preoperative duplex US scanning was per-
formed in 68% of the study group versus 28% of the
control group. Preoperative venography was performed
in 32% of the study group compared with 13% of the
control group.
Duplex US scanning enabled identification of veins
suitable for AVF creation but that were not visible at clinical
examination in 25% of patients. In 4% of patients, both
physical examination and duplex US scanning failed to
reveal a suitable vein, and thus venography was performed.
The preoperatively planned access configuration correlated
with the actual procedure performed in 98% of patients.
After implementation of preoperative imaging, the au-
togenous fistula creation rate increased from 61% to 73%
(P  .15; Fig 1). For the subset of patients undergoing a
first access procedure, the rate increased from 66% to 83%
(P  .05). The distribution of hemodialysis access config-
urations in the two groups is shown in Table II. The study
and control groups were comparable in distribution of
radiocephalic (22% vs 21%) and brachiocephalic (35% vs
36%) AVF placed. Use of basilic vein transposition in-
creased from 3% in the earlier period to 13% in the study
group (P .05). Creation of forearm AVG decreased from
30% in the control group to 11% in the study group (P 
.05).
Mean maturation time was 70 days for AVF and 34
days for prosthetic arteriovenous grafts in the study group,
compared with 82 days for AVF and 28 days for prosthetic




group Study group P
No. of access procedures 148 256
No. of patients 128 202






African American 4 7
Hispanic 38 31
Native American 3 7
Comorbid conditions (%)
Diabetes mellitus 62 64
Hypertension 51 70
Polycystic kidney disease 5 3
Autoimmune disease 8 6
First-time access (%) 78 63 .08






Preoperative venography (%) 13 32 .05*
*All other P values not significant.
Fig 1. Comparison of autogenous fistula creation rates.
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arteriovenous grafts in the study group. Additional inter-
ventions, such as operative revision, percutaneous translu-
minal angioplasty, and thrombectomy, were required to
achieve functional maturation in 19% of AVF and 4% of
prosthetic arteriovenous grafts. Functional maturation rate
for AVF declined from 73% to 57% (P  .05) after imple-
mentation of preoperative imaging and more aggressive
vein use during the study (Fig 2). There was no difference
in maturation rate between the various configurations. Of
25 basilic vein transpositions performed in the contempo-
rary period, 17 (68%) achieved functional maturation at a
mean interval of 67 days, and 18% required remedial pro-
cedures. Basilic vein transposition was the initial access
procedure in 29% and the secondary procedure in 71% of
patients. Maturation rate for access grafts constructed ex-
clusively on the basis of findings at physical examination
was 80%. Multivariate analysis identified brachiocephalic
configuration and AVF constructed on the basis of vein
identified solely by preoperative venography as factors pre-
dictive of failed maturation. Gender, race, diabetes melli-
tus, previous failed access, and vein diameter (2.5-3 cm vs
3 cm) did not affect probability of maturation. Failed
maturation was most commonly due to inadequate dilation
to permit cannulation. Central vein occlusion accounted
for only 3% of failed fistula maturation. There were no
documented cases of failed maturation due to inadequate
arterial flow or hand ischemia requiring ligation.
DISCUSSION
The ideal hemodialysis access fistula should be durable,
pose minimal risk for infection, and require few interven-
tions to maintain ongoing functional patency. It is well
documented that mature AVF demonstrate superior overall
patency, lower revision rate, and cost savings, compared
with prosthetic arteriovenous grafts.2-7,19 Despite almost
uniform agreement on the need to increase the AVF cre-
ation rate, prevalence in the United States has increased
only modestly since publication of DOQI clinical practice
guidelines in 1997. Less than 30% of access sites in the
United States are autogenous fistulas.7,10 Prosthetic arte-
riovenous grafts may be more appealing because of ease of
operative placement and cannulation, short interval re-
quired before use, anticipated limited life expectancy of
some patients, and greater financial reimbursement. Some
investigators have suggested that the greater early failure
rate of AVF results in overall patency equivalent to that of
prosthetic arteriovenous grafts.17,18 Repeated interven-
tions to establish access patency may exert a substantial
economic and emotional toll. An effective imaging proto-
col should maximize the number of patients receiving
functional access fistulas and minimize the number of un-
successful attempts at fistula construction.
Preoperative assessment with duplex US scanning and
venography may enable identification of veins not apparent
at clinical examination and thereby lead to insertion of
functional autogenous fistulas with superior longevity. Silva
et al11 increased the rate of native AVF in their practice
from 14% to 63% with routine preoperative duplex US
scanning. With a protocol consisting of duplex US scan-
ning, arteriography, and venography performed preopera-
tively in all patients, Huber et al12 created AVF in 90% of
patients. We found that a selective protocol of duplex US
scanning and venography enabled placement of autoge-
nous access in 73% of patients. For first-time access proce-
dures, this figure rose to 83%. However, even during the
historical control period, before liberal preoperative imag-
ing, our 61% rate of autogenous fistula creation exceeded
the 50% figure recommended by DOQI. This attests to our
lasting commitment in creating AVF even before more
aggressive attempts to increase vein use with preoperative
imaging. In our dialysis unit the prevalence of patients
undergoing dialysis with an AVF during the two observa-
tional periods increased from 41% to 52%, surpassing the
40% guideline mandated by DOQI.
The 13% increase in AVF rate in our current practice
compared with the historical control group can in large part
be attributed to the fourfold increase in basilic vein trans-
position, from 3% to 13%, during the study period. This








Pn % n %
Radiocephalic 31 21 56 22
Brachiocephalic 53 36 90 35
Basilic transposition 5 3 33 13 .05*
Forearm AVG 44 30 28 11 .05*
Upper arm AVG 12 8 36 14
Other (eg, lower extremity) 3 2 13 5
Total 148 256
AVG, Arteriovenous graft.
*All other P values not significant.
Fig 2. Comparison of autogenous functional maturation rates.
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change reflects an increasing preference for autogenous
basilic vein transposition over forearm prosthetic grafting
when imaging methods reveal a viable basilic vein. DOQI
guidelines recommend that when a brachiocephalic fistula
fails, either a basilic vein transposition or forearm prosthetic
arteriovenous graft be used. Fullerton et al20 observed an
increase in basilic vein transposition, from 0% to 26%, with
adoption of an imaging protocol. Among 125 new access
procedures performed with a rigorous preoperative imag-
ing protocol, Huber et al12 performed 49 basilic vein
transpositions (39%), in preference to forearm prosthetic
graft access, accounting for the leading AVF configuration
in their series. Basilic vein transposition has long-term
patency comparable to more traditional AVF.21,22 Whether
basilic vein transposition is superior to forearm prosthetic
arteriovenous graft is debatable, and will ultimately only be
determined with a prospective randomized study. Hakaim
et al16 reported a 70% nonmaturation rate for radiocephalic
AVF in patients with diabetes, and recommended more
liberal use of basilic vein transposition in this patient sub-
group.
One of the unexpected findings in our study was that
the functional maturation rate decreased, from 73% to 57%,
after implementation of a preoperative imaging protocol.
Although we were successful in creating more autogenous
fistulas, there were correspondingly more cases of failed
maturation. In contrast, Ascher et al5 observed that the
maturation rate increased, from 64% to 92%, with an imag-
ing protocol. Mihmanli et al23 found that preoperative
duplex US scanning improved short-term AVF patency,
from 75% to 94%, compared with physical examination
alone. Of interest, Allon et al24 demonstrated improved
maturation rate for lower arm AVF (34% to 54%) but not
upper arm AVF (59% to 56%) with implementation of an
imaging protocol. We failed to demonstrate any significant
differences between maturation rate of the various config-
urations. Perhaps, our reduction in functional maturation
reflects a change in our patient population over the two
periods of observation. A higher percentage of patients in
the study group compared with the historical control group
were already receiving dialysis at the time of index access
creation (36% vs 16%; P .05, and a greater percentage of
patients were undergoing repeat access creation (37% vs
22%; P  .08). We speculate that, in addition to a shift in
preference, the increase in basilic vein transposition per-
formed in the more recent period may reflect a group of
patients undergoing increasingly complex procedures, be-
cause these procedures were more often secondary proce-
dures.
Another possibility to account for our reduction in
maturation rate with implementation of an imaging pro-
tocol is a flaw in our selection criteria. Our criteria for
vein selection (vein diameter 2.5 mm) based on find-
ings at duplex US scanning and venography are similar to
those reported by other authors. Mendes et al13 found
that AVF constructed with cephalic vein larger than 2
mm proceeded to functional access in 76% of patients.
When cephalic vein with a minimal diameter less than 2
mm was used, a dismal maturation rate of 16% was
attained. In our practice, vein smaller than 2.5 mm in
diameter were almost never used. The criteria of Huber
et al8 for vein suitability included vein diameter greater
than 3 mm, without evidence of stenosis. They were able
to achieve a maturation rate of 84%.
Our study differs from others in that we did not
routinely perform duplex US scanning in all patients
(Table III). If an excellent vein was identified at physical
examination, it was used for AVF creation without fur-
ther imaging. The maturation rate for such AVF was
80%. It is unlikely that duplex US scanning of these veins
would have improved results. Including such patients in
a preoperative duplex US scanning protocol will artifi-
cially improve the estimated utility of the technique. If
there was any question about vein adequacy, duplex US
scanning was performed. We thus increased the fre-
quency of preoperative duplex US scanning from 28% to
68%, and for preoperative venography from 13% to 32%.
The maturation rate of duplex US scanning only–identi-
fied vein was 75%, and for venography only–identified
vein was 46%. Furthermore, the proportion of patients
with diabetes in our study (64%) exceeded that reported
by other authors (24%-49%; Table III). Because diabetes















Year 1998 2000 2000 2002 2002 2002 2003
No. of access produced 267* 183 139 748 256
No. of patients 160 137* 52 163 131 748 202
Diabetes mellitus (%) 31† 55 44 42 49 24 64
Duplex ultrasound scanning (%) 100 Selective 100 100 100 80-90 68
Vein-size threshold (mm) 2.5 2-3 2.5 3 3 2.5
Fistula rate (%) 68‡ 68* 58 23 90 100 73
Transposition rate (%) 14 6 35 13
Fistula maturation rate (%) 92‡ 82 79 84 57
*Includes revisions and temporary access procedures.
†Includes patients undergoing permanent catheter placement
‡Rate determined based on total number of patients (not total number of procedures)
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adversely affects AVF maturation, this may have contrib-
uted to our reduced maturation rate in comparison with
other studies.16,25,26 Vein diameter, continuity, lack of
significant sclerosis, and compressibility are all estab-
lished with duplex US scanning. It may be that the
quality of vein visible on inspection is inherently superior
to that visualized only with duplex US scanning or
venography. Indeed, our data demonstrate that the mat-
uration rate of fistulas constructed solely on the basis of
imaging is inferior.
Large reported differences in type of vascular access
created exist between the United States and Europe. Data
from DOPPS indicate that European practices are highly
successful in placing AVF. In Europe AVF account for 80%
of all access sites. In contrast, data from DOPPS indicate
that AVF are placed in 24% of prevalent patients and 15% of
incident patients in the United States.7,27 Konner et al,28 in
Cologne, Germany, report that between 1993 and 1998,
748 consecutive patients underwent construction of a pri-
mary AVF; in no case was it necessary to create an AVG.
Duplex US scanning and venography were used selectively.
Of interest, only 24% of their patients had diabetes. In
DOPPS, 22% of European patients had diabetes mellitus,
compared with 46% of US patients.7 We postulate that
patients in Europe compose an entirely different popula-
tion group. Although European access surgeons may more
aggressively attempt to place AVF compared with their
American counterparts, we suspect that some of these
differences in practice patterns are due to inherent differ-
ences in patient populations.
In conclusion, implementation of routine preoperative
duplex US scanning likely will increase the AVF creation
rate in a given vascular access practice. However, in a
practice in which the philosophy of native AVF creation is
ingrained, net increase in AVF creation rate is less than
previously reported. In our experience, we were able to
increase AVF creation in first-time patients from 66% to
83%, and in all patients from 61% to 73%, after adoption of
a preoperative imaging protocol. However, as an unin-
tended sequela, we noted an overall decrease in functional
AVF maturation rate, from 73% to 57%. An acceptable AVF
maturation rate will need to be defined so that we can
maximize the number of patients who subsequently will
have a functional access fistula without undergoing an
inordinate number of unnecessary AVF procedures that are
destined from the outset to fail. It may be that an AVF
created on the basis of vein identification at duplex US
scanning is inferior to one created on the basis of vein
identification at physical examination. While our group will
continue to use preoperative duplex US scanning vein
mapping, we suggest that improved predictive criteria for
success are required and that the proposed benefits of such
a protocol may have been overstated.
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DISCUSSION
Dr Thomas S. Huber (Gainesville, Fla). I would like to lead
off the discussion, and I must confess the authors scooped me on a
few of my questions.
The authors report a retrospective review of their access prac-
tice before and after the introduction of preoperative imaging
protocol including duplex ultrasound and venography. They re-
port their native fistula utilization rate increased from approxi-
mately 60% to 70% after the introduction of the protocol. How-
ever, the rate of mature fistulas suitable for dialysis access decreased
from approximately 70% to 60%. Based upon these results the
authors concluded that the benefits of extensive preoperative im-
aging as part of the evaluation for patients referred for dialysis
access are overstated, although they do concede that they will
continue to use these modalities in their practice.
I laud the authors’ efforts to challenge several recent publica-
tions extolling the benefits of preoperative imaging prior to access
surgery, and I recommend their well-written manuscript to the
audience. However, I urge their results and conclusions be inter-
preted with some caution, and I fear that the manuscript may have
the unintentional consequence of increasing the placement of
prosthetic arteriovenous fistulae. My specific concerns are twofold.
First, although the authors stated their purpose was to examine the
success of access procedures performed after the introduction of an
imaging protocol, approximately one third of the patients under-
went preoperative duplex ultrasound in the historical control
group and only two thirds underwent preoperative duplex imaging
after initiation of the protocol. A more rigorous evaluation of the
preoperative imaging would have compared physical examination
alone to the various imaging modalities, and ideally would have
been performed in a prospective randomized fashion.
Second, the authors’ native fistula rate prior to the initiation of
the study exceeded 60% and was well above the targets established
by the NFK-DOQI guidelines, in stark contrast to the 17% nation-
wide rate reported in the Dartmouth Atlas. Additional preopera-
tive imaging may not prove very beneficial to identify good native
fistula options in this setting, because their pre-study approach was
so effective. In light of these concerns, I would contend that the
study is an incrimination of the authors’ criteria for native fistula
rather than the imaging modalities themselves.
I have three questions for the authors. First, the reported
fistula maturation rates were relatively low, given the wide range
reported in the literature. Have you examined or documented the
various potential reasons why the fistula failed to mature? Indeed,
there are multiple potential causes, including failure of the fistula to
dilate, fistula stenosis, central vein occlusions, inadequate arterial
inflow, and hand ischemia requiring ligation.
Second, the 2.5 mm criterion used to determine whether a
vein was suitable for a native fistula seemed relatively aggressive,
and may have contributed to the low fistula maturation rate. In our
own practice, we have used a 3 mm cutoff, but have been anecdot-
ally impressed that even this may be too aggressive. It has been our
experience that bigger clearly is better and that veins with larger
diameters translate into better success rates. Did you analyze the
impact of vein diameters on the fistula success rate or incorporate
this variable into your multivariate analysis?
And last, despite your results, I was impressed by the statement
in your conclusions that you will continue to use preoperative
duplex imaging. What are your current recommendations to less
experienced access surgeons for preoperative evaluation given the
NFK-DOQI targets for native fistula utilization?
Dr Sheela Thakor Patel. Thank you, Dr Huber, for your
discussion.
If we had an AV fistula that was not maturing by 6 to 8 weeks,
we always performed diagnostic imaging to see what the problem
was. The most common reason why fistula failed was failure of the
veins to dilate or thrombosis, which was most commonly due to
stenosis close to the anastomosis. The most common adjunctive
procedure that we performed to assist in maturation was angio-
plasty, which was successful in about 50% of the cases. We only had
one case where the documented case of AV fistula failure was an
arterial problem, an arterial stenosis.
To address your second question, we did use 2.5 mm vein
criteria, based on published studies, and we did not examine the
impact of vein diameter in our study. We currently recommend
that patients who have visible veins on physical examination, when
there is no question of continuity, then those patients do not need
to be imaged. Only those patients in whom there is a question of
continuity or quality or caliber of the vessels, those patients should
get imaging.
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